Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Assets (2017 - 2025)

Historic Return on Assets for Akebia Therapeutics (AKBA) over the last 10 years, with Q3 2025 value amounting to 0.04%.

  • Akebia Therapeutics' Return on Assets rose 1700.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.3% for FY2024, which is 1300.0% down from last year.
  • As of Q3 2025, Akebia Therapeutics' Return on Assets stood at 0.04%, which was up 1700.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Return on Assets ranged from a high of 0.04% in Q3 2025 and a low of 0.62% during Q1 2021
  • Its 5-year average for Return on Assets is 0.3%, with a median of 0.24% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -2800bps in 2021, then soared by 3400bps in 2023.
  • Quarter analysis of 5 years shows Akebia Therapeutics' Return on Assets stood at 0.5% in 2021, then soared by 52bps to 0.24% in 2022, then grew by 10bps to 0.22% in 2023, then crashed by -49bps to 0.32% in 2024, then skyrocketed by 86bps to 0.04% in 2025.
  • Its last three reported values are 0.04% in Q3 2025, 0.11% for Q2 2025, and 0.17% during Q1 2025.